Percutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women A Statement for Healthcare Professionals From the American Heart Association
2005
More than 1.2 million percutaneous coronary interventions are performed annually in the United States, with only an estimated 33% performed in women, despite the established benefits of percutaneous coronary intervention and adjunctive pharmacotherapy in reducing fatal and nonfatal ischemic complications in acute myocardial infarction and high-risk acute coronary syndromes. This statement reviews sex-specific data on the safety and efficacy of contemporary interventional therapies in women.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
161
References
225
Citations
NaN
KQI